<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03524950</url>
  </required_header>
  <id_info>
    <org_study_id>D to stress study of pituitrin</org_study_id>
    <nct_id>NCT03524950</nct_id>
  </id_info>
  <brief_title>Effect of Dexmedetomidine on Stress Study of Pituitrin in Laparoscopic Hysteromyoma Surgery</brief_title>
  <official_title>Effect of Dexmedetomidine on Stress Study of Pituitrin in Laparoscopic Hysteromyoma Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is about the effect of dexmedetomidine to the stress of pituitrin in laparoscopic
      hysteromyoma surgery. It is well known that pituitrin has been widespread used in the
      laparoscopic hysteromyoma surgery. Pituitrin includes oxytocin and vasopressin. Vasopressin
      increase body stress reaction through hypothalamic pituitary adrenal(HPA) axis. The HPA axis
      has has main role to the body stress reaction. Dexmedetomidine can inhibit the stress
      responses mediated by the sympathetic nervous system. Therefore,the effect of dexmedetomidine
      to the stress of pituitrin in laparoscopic hysteromyoma surgery is worth to be studied.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>acth</measure>
    <time_frame>the acth before using pituitrin 5 minutes</time_frame>
    <description>adrenocorticotropic hormone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>acth</measure>
    <time_frame>the acth after using pituitrin 20 minutes</time_frame>
    <description>adrenocorticotropic hormone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>acth</measure>
    <time_frame>the acth after using pituitrin 120 minutes</time_frame>
    <description>adrenocorticotropic hormone</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Hysteromyoma</condition>
  <arm_group>
    <arm_group_label>no dexmedetomidine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>high dose dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>low dose dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Ninety patients will be assigned to three groups. Group A add saline in general anesthesia laparoscopic hysteromyoma surgery. Group B add dexmedetomidine 1μg/Kg10minutes as loading dose, followed by 0.7μg/Kg/h for maintenance.Group C add dexmedetomidine 0.7μg/Kg10minutes as loading dose, followed by 0.5μg/Kg/h for maintenance.</description>
    <arm_group_label>high dose dexmedetomidine</arm_group_label>
    <arm_group_label>low dose dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Surgery will be scheduled as first case in the morning at 9 Am. On arrival to the operation
        room, intravenous access will be achieved with venous cannula under local anesthesia with
        2% lidocaine. Monitoring consisted of 5 lead electrocardiography, pulse oximeter,
        noninvasive blood pressure, end tidal carbon dioxide, and bispectral index.

        Exclusion Criteria:

        Diabetic,chronic hypertension,patients on drugs such as beta blockers or calcium channel
        blockers,pregnant or lactating women, patients with abnormal serum creatinine and blood
        urea nitrogen, and patients with a history of allergy to drugs particularly α2 agonists.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xia Cao, M.D.Candidate</last_name>
    <phone>+86-13811239739</phone>
    <email>13811239739@139.com</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2018</study_first_submitted>
  <study_first_submitted_qc>May 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2018</study_first_posted>
  <last_update_submitted>May 13, 2018</last_update_submitted>
  <last_update_submitted_qc>May 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Xia CAO</investigator_full_name>
    <investigator_title>student</investigator_title>
  </responsible_party>
  <keyword>stress</keyword>
  <keyword>dexmedetomidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

